These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Tear film osmolarity in patients treated for glaucoma or ocular hypertension. Labbé A, Terry O, Brasnu E, Van Went C, Baudouin C. Cornea; 2012 Sep; 31(9):994-9. PubMed ID: 22710490 [Abstract] [Full Text] [Related]
7. [Corneal sensitivity in patients treated medically for glaucoma or ocular hypertension]. Van Went C, Alalwani H, Brasnu E, Pham J, Hamard P, Baudouin C, Labbé A. J Fr Ophtalmol; 2011 Dec; 34(10):684-90. PubMed ID: 22093372 [Abstract] [Full Text] [Related]
8. Ocular surface disease and glaucoma: how to evaluate impact on quality of life. Rossi GC, Pasinetti GM, Scudeller L, Bianchi PE. J Ocul Pharmacol Ther; 2013 May; 29(4):390-4. PubMed ID: 23215770 [Abstract] [Full Text] [Related]
9. Corneal and conjunctival sensitivity in patients with dry eye: the effect of topical cyclosporine therapy. Toker E, Asfuroğlu E. Cornea; 2010 Feb; 29(2):133-40. PubMed ID: 19966564 [Abstract] [Full Text] [Related]
10. Clinical audit examining the impact of benzalkonium chloride-free anti-glaucoma medications on patients with symptoms of ocular surface disease. Goldberg I, Graham SL, Crowston JG, d'Mellow G, Australian and New Zealand Glaucoma Interest Group. Clin Exp Ophthalmol; 2015 Apr; 43(3):214-20. PubMed ID: 25196488 [Abstract] [Full Text] [Related]
16. The features of dry eye disease in a Japanese elderly population. Uchino M, Dogru M, Yagi Y, Goto E, Tomita M, Kon T, Saiki M, Matsumoto Y, Uchino Y, Yokoi N, Kinoshita S, Tsubota K. Optom Vis Sci; 2006 Nov; 83(11):797-802. PubMed ID: 17106406 [Abstract] [Full Text] [Related]
18. Usefulness of double vital staining with 1% fluorescein and 1% lissamine green in patients with dry eye syndrome. Yoon KC, Im SK, Kim HG, You IC. Cornea; 2011 Sep; 30(9):972-6. PubMed ID: 21705877 [Abstract] [Full Text] [Related]